nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Vincristine—sarcoma	0.167	0.229	CbGbCtD
Levetiracetam—ABCC2—Etoposide—sarcoma	0.153	0.21	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—sarcoma	0.105	0.143	CbGbCtD
Levetiracetam—ABCB1—Dactinomycin—sarcoma	0.0886	0.121	CbGbCtD
Levetiracetam—ABCB1—Mitoxantrone—sarcoma	0.0793	0.108	CbGbCtD
Levetiracetam—ABCB1—Vincristine—sarcoma	0.0546	0.0746	CbGbCtD
Levetiracetam—ABCB1—Etoposide—sarcoma	0.05	0.0683	CbGbCtD
Levetiracetam—ABCB1—Doxorubicin—sarcoma	0.0341	0.0466	CbGbCtD
Levetiracetam—SV2A—myometrium—sarcoma	0.00564	0.208	CbGeAlD
Levetiracetam—SV2A—seminal vesicle—sarcoma	0.00509	0.188	CbGeAlD
Levetiracetam—CACNA1B—connective tissue—sarcoma	0.00322	0.119	CbGeAlD
Levetiracetam—SV2A—testis—sarcoma	0.00265	0.098	CbGeAlD
Levetiracetam—SV2A—lymph node—sarcoma	0.00192	0.071	CbGeAlD
Levetiracetam—CACNA1B—testis—sarcoma	0.00183	0.0677	CbGeAlD
Levetiracetam—CACNA1B—lymph node—sarcoma	0.00133	0.0491	CbGeAlD
Levetiracetam—ABCC2—tendon—sarcoma	0.000717	0.0265	CbGeAlD
Levetiracetam—ABCC2—testis—sarcoma	0.000594	0.0219	CbGeAlD
Levetiracetam—ABCC2—liver—sarcoma	0.000562	0.0207	CbGeAlD
Levetiracetam—ABCB1—myometrium—sarcoma	0.000454	0.0168	CbGeAlD
Levetiracetam—ABCB1—embryo—sarcoma	0.000437	0.0161	CbGeAlD
Levetiracetam—ABCC2—lymph node—sarcoma	0.000431	0.0159	CbGeAlD
Levetiracetam—Cough—Etoposide—sarcoma	0.000421	0.00175	CcSEcCtD
Levetiracetam—Somnolence—Mitoxantrone—sarcoma	0.00042	0.00175	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Vincristine—sarcoma	0.000419	0.00174	CcSEcCtD
Levetiracetam—Fatigue—Vincristine—sarcoma	0.000419	0.00174	CcSEcCtD
Levetiracetam—Convulsion—Etoposide—sarcoma	0.000418	0.00173	CcSEcCtD
Levetiracetam—Dehydration—Epirubicin—sarcoma	0.000417	0.00173	CcSEcCtD
Levetiracetam—Hyponatraemia—Doxorubicin—sarcoma	0.000417	0.00173	CcSEcCtD
Levetiracetam—Dyspepsia—Mitoxantrone—sarcoma	0.000416	0.00173	CcSEcCtD
Levetiracetam—Pain—Vincristine—sarcoma	0.000415	0.00172	CcSEcCtD
Levetiracetam—Constipation—Vincristine—sarcoma	0.000415	0.00172	CcSEcCtD
Levetiracetam—Diplopia—Doxorubicin—sarcoma	0.000415	0.00172	CcSEcCtD
Levetiracetam—Liver function test abnormal—Epirubicin—sarcoma	0.000414	0.00172	CcSEcCtD
Levetiracetam—Decreased appetite—Mitoxantrone—sarcoma	0.000411	0.00171	CcSEcCtD
Levetiracetam—Chest pain—Etoposide—sarcoma	0.00041	0.0017	CcSEcCtD
Levetiracetam—ABCB1—seminal vesicle—sarcoma	0.00041	0.0151	CbGeAlD
Levetiracetam—Abdominal pain upper—Epirubicin—sarcoma	0.00041	0.0017	CcSEcCtD
Levetiracetam—Affect lability—Doxorubicin—sarcoma	0.000409	0.0017	CcSEcCtD
Levetiracetam—Fatigue—Mitoxantrone—sarcoma	0.000408	0.00169	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000408	0.00169	CcSEcCtD
Levetiracetam—Pain—Mitoxantrone—sarcoma	0.000404	0.00168	CcSEcCtD
Levetiracetam—Constipation—Mitoxantrone—sarcoma	0.000404	0.00168	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000404	0.00168	CcSEcCtD
Levetiracetam—Hypersensitivity—Thiotepa—sarcoma	0.000403	0.00168	CcSEcCtD
Levetiracetam—Nasopharyngitis—Epirubicin—sarcoma	0.000401	0.00167	CcSEcCtD
Levetiracetam—Face oedema—Doxorubicin—sarcoma	0.000401	0.00166	CcSEcCtD
Levetiracetam—Hypersensitivity—Dactinomycin—sarcoma	0.0004	0.00166	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Vincristine—sarcoma	0.000397	0.00165	CcSEcCtD
Levetiracetam—Confusional state—Etoposide—sarcoma	0.000397	0.00165	CcSEcCtD
Levetiracetam—Muscular weakness—Epirubicin—sarcoma	0.000396	0.00164	CcSEcCtD
Levetiracetam—Mood swings—Doxorubicin—sarcoma	0.000393	0.00163	CcSEcCtD
Levetiracetam—Asthenia—Thiotepa—sarcoma	0.000393	0.00163	CcSEcCtD
Levetiracetam—Infection—Etoposide—sarcoma	0.000391	0.00162	CcSEcCtD
Levetiracetam—Ataxia—Doxorubicin—sarcoma	0.00039	0.00162	CcSEcCtD
Levetiracetam—Asthenia—Dactinomycin—sarcoma	0.00039	0.00162	CcSEcCtD
Levetiracetam—ABCB1—hematopoietic system—sarcoma	0.00039	0.0144	CbGeAlD
Levetiracetam—Feeling abnormal—Mitoxantrone—sarcoma	0.00039	0.00162	CcSEcCtD
Levetiracetam—Influenza—Epirubicin—sarcoma	0.000388	0.00161	CcSEcCtD
Levetiracetam—Asthma—Epirubicin—sarcoma	0.000388	0.00161	CcSEcCtD
Levetiracetam—Pruritus—Thiotepa—sarcoma	0.000387	0.00161	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000387	0.00161	CcSEcCtD
Levetiracetam—Dehydration—Doxorubicin—sarcoma	0.000386	0.0016	CcSEcCtD
Levetiracetam—Thrombocytopenia—Etoposide—sarcoma	0.000385	0.0016	CcSEcCtD
Levetiracetam—Eosinophilia—Epirubicin—sarcoma	0.000384	0.00159	CcSEcCtD
Levetiracetam—Body temperature increased—Vincristine—sarcoma	0.000384	0.00159	CcSEcCtD
Levetiracetam—Abdominal pain—Vincristine—sarcoma	0.000384	0.00159	CcSEcCtD
Levetiracetam—Liver function test abnormal—Doxorubicin—sarcoma	0.000383	0.00159	CcSEcCtD
Levetiracetam—Skin disorder—Etoposide—sarcoma	0.000382	0.00159	CcSEcCtD
Levetiracetam—Pancreatitis—Epirubicin—sarcoma	0.00038	0.00158	CcSEcCtD
Levetiracetam—Abdominal pain upper—Doxorubicin—sarcoma	0.000379	0.00157	CcSEcCtD
Levetiracetam—Anorexia—Etoposide—sarcoma	0.000375	0.00156	CcSEcCtD
Levetiracetam—Diarrhoea—Thiotepa—sarcoma	0.000375	0.00156	CcSEcCtD
Levetiracetam—Body temperature increased—Mitoxantrone—sarcoma	0.000374	0.00155	CcSEcCtD
Levetiracetam—Abdominal pain—Mitoxantrone—sarcoma	0.000374	0.00155	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000374	0.00155	CcSEcCtD
Levetiracetam—Bronchitis—Epirubicin—sarcoma	0.000373	0.00155	CcSEcCtD
Levetiracetam—Diarrhoea—Dactinomycin—sarcoma	0.000372	0.00154	CcSEcCtD
Levetiracetam—Nasopharyngitis—Doxorubicin—sarcoma	0.000371	0.00154	CcSEcCtD
Levetiracetam—Pancytopenia—Epirubicin—sarcoma	0.000368	0.00153	CcSEcCtD
Levetiracetam—Muscular weakness—Doxorubicin—sarcoma	0.000366	0.00152	CcSEcCtD
Levetiracetam—Neutropenia—Epirubicin—sarcoma	0.000363	0.00151	CcSEcCtD
Levetiracetam—Dizziness—Thiotepa—sarcoma	0.000362	0.0015	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Epirubicin—sarcoma	0.00036	0.0015	CcSEcCtD
Levetiracetam—Influenza—Doxorubicin—sarcoma	0.000359	0.00149	CcSEcCtD
Levetiracetam—Asthma—Doxorubicin—sarcoma	0.000359	0.00149	CcSEcCtD
Levetiracetam—Hypersensitivity—Vincristine—sarcoma	0.000358	0.00149	CcSEcCtD
Levetiracetam—Eosinophilia—Doxorubicin—sarcoma	0.000355	0.00148	CcSEcCtD
Levetiracetam—Paraesthesia—Etoposide—sarcoma	0.000353	0.00147	CcSEcCtD
Levetiracetam—Weight increased—Epirubicin—sarcoma	0.000353	0.00147	CcSEcCtD
Levetiracetam—Pancreatitis—Doxorubicin—sarcoma	0.000352	0.00146	CcSEcCtD
Levetiracetam—Weight decreased—Epirubicin—sarcoma	0.000351	0.00146	CcSEcCtD
Levetiracetam—Somnolence—Etoposide—sarcoma	0.00035	0.00145	CcSEcCtD
Levetiracetam—Hypersensitivity—Mitoxantrone—sarcoma	0.000348	0.00145	CcSEcCtD
Levetiracetam—Asthenia—Vincristine—sarcoma	0.000348	0.00145	CcSEcCtD
Levetiracetam—Vomiting—Thiotepa—sarcoma	0.000348	0.00145	CcSEcCtD
Levetiracetam—Infestation NOS—Epirubicin—sarcoma	0.000346	0.00144	CcSEcCtD
Levetiracetam—Infestation—Epirubicin—sarcoma	0.000346	0.00144	CcSEcCtD
Levetiracetam—Drowsiness—Epirubicin—sarcoma	0.000346	0.00144	CcSEcCtD
Levetiracetam—Vomiting—Dactinomycin—sarcoma	0.000346	0.00144	CcSEcCtD
Levetiracetam—Rash—Thiotepa—sarcoma	0.000345	0.00143	CcSEcCtD
Levetiracetam—Bronchitis—Doxorubicin—sarcoma	0.000345	0.00143	CcSEcCtD
Levetiracetam—Dermatitis—Thiotepa—sarcoma	0.000345	0.00143	CcSEcCtD
Levetiracetam—Headache—Thiotepa—sarcoma	0.000343	0.00142	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000343	0.00142	CcSEcCtD
Levetiracetam—Rash—Dactinomycin—sarcoma	0.000343	0.00142	CcSEcCtD
Levetiracetam—Decreased appetite—Etoposide—sarcoma	0.000342	0.00142	CcSEcCtD
Levetiracetam—Pancytopenia—Doxorubicin—sarcoma	0.000341	0.00141	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Etoposide—sarcoma	0.00034	0.00141	CcSEcCtD
Levetiracetam—Asthenia—Mitoxantrone—sarcoma	0.000339	0.00141	CcSEcCtD
Levetiracetam—Fatigue—Etoposide—sarcoma	0.000339	0.00141	CcSEcCtD
Levetiracetam—Stomatitis—Epirubicin—sarcoma	0.000337	0.0014	CcSEcCtD
Levetiracetam—Pain—Etoposide—sarcoma	0.000336	0.0014	CcSEcCtD
Levetiracetam—Constipation—Etoposide—sarcoma	0.000336	0.0014	CcSEcCtD
Levetiracetam—Urinary tract infection—Epirubicin—sarcoma	0.000336	0.0014	CcSEcCtD
Levetiracetam—Conjunctivitis—Epirubicin—sarcoma	0.000336	0.0014	CcSEcCtD
Levetiracetam—Neutropenia—Doxorubicin—sarcoma	0.000335	0.00139	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000333	0.00138	CcSEcCtD
Levetiracetam—Diarrhoea—Vincristine—sarcoma	0.000332	0.00138	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Epirubicin—sarcoma	0.000327	0.00136	CcSEcCtD
Levetiracetam—Weight increased—Doxorubicin—sarcoma	0.000327	0.00136	CcSEcCtD
Levetiracetam—Epistaxis—Epirubicin—sarcoma	0.000326	0.00135	CcSEcCtD
Levetiracetam—Nausea—Thiotepa—sarcoma	0.000325	0.00135	CcSEcCtD
Levetiracetam—Weight decreased—Doxorubicin—sarcoma	0.000325	0.00135	CcSEcCtD
Levetiracetam—Sinusitis—Epirubicin—sarcoma	0.000324	0.00135	CcSEcCtD
Levetiracetam—Feeling abnormal—Etoposide—sarcoma	0.000324	0.00135	CcSEcCtD
Levetiracetam—Diarrhoea—Mitoxantrone—sarcoma	0.000324	0.00134	CcSEcCtD
Levetiracetam—Nausea—Dactinomycin—sarcoma	0.000323	0.00134	CcSEcCtD
Levetiracetam—Agranulocytosis—Epirubicin—sarcoma	0.000323	0.00134	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Etoposide—sarcoma	0.000322	0.00134	CcSEcCtD
Levetiracetam—Dizziness—Vincristine—sarcoma	0.000321	0.00133	CcSEcCtD
Levetiracetam—Infestation—Doxorubicin—sarcoma	0.00032	0.00133	CcSEcCtD
Levetiracetam—Infestation NOS—Doxorubicin—sarcoma	0.00032	0.00133	CcSEcCtD
Levetiracetam—Drowsiness—Doxorubicin—sarcoma	0.00032	0.00133	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000317	0.00132	CcSEcCtD
Levetiracetam—Stomatitis—Doxorubicin—sarcoma	0.000312	0.00129	CcSEcCtD
Levetiracetam—Rhinitis—Epirubicin—sarcoma	0.000311	0.00129	CcSEcCtD
Levetiracetam—Body temperature increased—Etoposide—sarcoma	0.000311	0.00129	CcSEcCtD
Levetiracetam—Abdominal pain—Etoposide—sarcoma	0.000311	0.00129	CcSEcCtD
Levetiracetam—Conjunctivitis—Doxorubicin—sarcoma	0.000311	0.00129	CcSEcCtD
Levetiracetam—Urinary tract infection—Doxorubicin—sarcoma	0.000311	0.00129	CcSEcCtD
Levetiracetam—Hepatitis—Epirubicin—sarcoma	0.00031	0.00129	CcSEcCtD
Levetiracetam—Vomiting—Vincristine—sarcoma	0.000309	0.00128	CcSEcCtD
Levetiracetam—Pharyngitis—Epirubicin—sarcoma	0.000308	0.00128	CcSEcCtD
Levetiracetam—Rash—Vincristine—sarcoma	0.000306	0.00127	CcSEcCtD
Levetiracetam—Dermatitis—Vincristine—sarcoma	0.000306	0.00127	CcSEcCtD
Levetiracetam—Connective tissue disorder—Epirubicin—sarcoma	0.000305	0.00127	CcSEcCtD
Levetiracetam—Headache—Vincristine—sarcoma	0.000304	0.00126	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Doxorubicin—sarcoma	0.000303	0.00126	CcSEcCtD
Levetiracetam—Epistaxis—Doxorubicin—sarcoma	0.000302	0.00125	CcSEcCtD
Levetiracetam—Vomiting—Mitoxantrone—sarcoma	0.000301	0.00125	CcSEcCtD
Levetiracetam—Sinusitis—Doxorubicin—sarcoma	0.0003	0.00125	CcSEcCtD
Levetiracetam—Agranulocytosis—Doxorubicin—sarcoma	0.000299	0.00124	CcSEcCtD
Levetiracetam—Rash—Mitoxantrone—sarcoma	0.000298	0.00124	CcSEcCtD
Levetiracetam—Dermatitis—Mitoxantrone—sarcoma	0.000298	0.00124	CcSEcCtD
Levetiracetam—Headache—Mitoxantrone—sarcoma	0.000296	0.00123	CcSEcCtD
Levetiracetam—ABCB1—uterus—sarcoma	0.000294	0.0109	CbGeAlD
Levetiracetam—Erythema multiforme—Epirubicin—sarcoma	0.000293	0.00122	CcSEcCtD
Levetiracetam—Eye disorder—Epirubicin—sarcoma	0.00029	0.0012	CcSEcCtD
Levetiracetam—Hypersensitivity—Etoposide—sarcoma	0.00029	0.0012	CcSEcCtD
Levetiracetam—Nausea—Vincristine—sarcoma	0.000288	0.0012	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—sarcoma	0.000288	0.0012	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—sarcoma	0.000287	0.00119	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—sarcoma	0.000285	0.00118	CcSEcCtD
Levetiracetam—Asthenia—Etoposide—sarcoma	0.000282	0.00117	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—sarcoma	0.000282	0.00117	CcSEcCtD
Levetiracetam—Nausea—Mitoxantrone—sarcoma	0.000281	0.00117	CcSEcCtD
Levetiracetam—Immune system disorder—Epirubicin—sarcoma	0.00028	0.00116	CcSEcCtD
Levetiracetam—Mediastinal disorder—Epirubicin—sarcoma	0.00028	0.00116	CcSEcCtD
Levetiracetam—Pruritus—Etoposide—sarcoma	0.000278	0.00116	CcSEcCtD
Levetiracetam—ABCB1—lymphoid tissue—sarcoma	0.000274	0.0101	CbGeAlD
Levetiracetam—Alopecia—Epirubicin—sarcoma	0.000274	0.00114	CcSEcCtD
Levetiracetam—Mental disorder—Epirubicin—sarcoma	0.000272	0.00113	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—sarcoma	0.000272	0.00113	CcSEcCtD
Levetiracetam—Malnutrition—Epirubicin—sarcoma	0.00027	0.00112	CcSEcCtD
Levetiracetam—Diarrhoea—Etoposide—sarcoma	0.000269	0.00112	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—sarcoma	0.000268	0.00111	CcSEcCtD
Levetiracetam—Tension—Epirubicin—sarcoma	0.000265	0.0011	CcSEcCtD
Levetiracetam—Nervousness—Epirubicin—sarcoma	0.000262	0.00109	CcSEcCtD
Levetiracetam—Back pain—Epirubicin—sarcoma	0.000261	0.00109	CcSEcCtD
Levetiracetam—Dizziness—Etoposide—sarcoma	0.00026	0.00108	CcSEcCtD
Levetiracetam—Immune system disorder—Doxorubicin—sarcoma	0.000259	0.00108	CcSEcCtD
Levetiracetam—Mediastinal disorder—Doxorubicin—sarcoma	0.000259	0.00107	CcSEcCtD
Levetiracetam—Vision blurred—Epirubicin—sarcoma	0.000255	0.00106	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—sarcoma	0.000254	0.00105	CcSEcCtD
Levetiracetam—Mental disorder—Doxorubicin—sarcoma	0.000252	0.00104	CcSEcCtD
Levetiracetam—Vomiting—Etoposide—sarcoma	0.00025	0.00104	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—sarcoma	0.00025	0.00104	CcSEcCtD
Levetiracetam—ABCB1—bone marrow—sarcoma	0.00025	0.00923	CbGeAlD
Levetiracetam—Agitation—Epirubicin—sarcoma	0.000248	0.00103	CcSEcCtD
Levetiracetam—Rash—Etoposide—sarcoma	0.000248	0.00103	CcSEcCtD
Levetiracetam—Dermatitis—Etoposide—sarcoma	0.000248	0.00103	CcSEcCtD
Levetiracetam—Headache—Etoposide—sarcoma	0.000246	0.00102	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—sarcoma	0.000245	0.00102	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—sarcoma	0.000243	0.00101	CcSEcCtD
Levetiracetam—Vertigo—Epirubicin—sarcoma	0.000243	0.00101	CcSEcCtD
Levetiracetam—Leukopenia—Epirubicin—sarcoma	0.000242	0.001	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—sarcoma	0.000242	0.001	CcSEcCtD
Levetiracetam—Cough—Epirubicin—sarcoma	0.000236	0.000979	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—sarcoma	0.000236	0.000978	CcSEcCtD
Levetiracetam—Convulsion—Epirubicin—sarcoma	0.000234	0.000972	CcSEcCtD
Levetiracetam—Nausea—Etoposide—sarcoma	0.000234	0.00097	CcSEcCtD
Levetiracetam—Arthralgia—Epirubicin—sarcoma	0.00023	0.000955	CcSEcCtD
Levetiracetam—Chest pain—Epirubicin—sarcoma	0.00023	0.000955	CcSEcCtD
Levetiracetam—Myalgia—Epirubicin—sarcoma	0.00023	0.000955	CcSEcCtD
Levetiracetam—Agitation—Doxorubicin—sarcoma	0.00023	0.000954	CcSEcCtD
Levetiracetam—Anxiety—Epirubicin—sarcoma	0.000229	0.000952	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000228	0.000949	CcSEcCtD
Levetiracetam—Vertigo—Doxorubicin—sarcoma	0.000225	0.000933	CcSEcCtD
Levetiracetam—Leukopenia—Doxorubicin—sarcoma	0.000224	0.000929	CcSEcCtD
Levetiracetam—Confusional state—Epirubicin—sarcoma	0.000222	0.000923	CcSEcCtD
Levetiracetam—Infection—Epirubicin—sarcoma	0.000219	0.00091	CcSEcCtD
Levetiracetam—Cough—Doxorubicin—sarcoma	0.000218	0.000906	CcSEcCtD
Levetiracetam—Convulsion—Doxorubicin—sarcoma	0.000217	0.000899	CcSEcCtD
Levetiracetam—Nervous system disorder—Epirubicin—sarcoma	0.000216	0.000898	CcSEcCtD
Levetiracetam—Thrombocytopenia—Epirubicin—sarcoma	0.000216	0.000897	CcSEcCtD
Levetiracetam—Skin disorder—Epirubicin—sarcoma	0.000214	0.000889	CcSEcCtD
Levetiracetam—ABCB1—testis—sarcoma	0.000214	0.00789	CbGeAlD
Levetiracetam—Arthralgia—Doxorubicin—sarcoma	0.000213	0.000884	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—sarcoma	0.000213	0.000884	CcSEcCtD
Levetiracetam—Myalgia—Doxorubicin—sarcoma	0.000213	0.000884	CcSEcCtD
Levetiracetam—Anxiety—Doxorubicin—sarcoma	0.000212	0.000881	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000211	0.000878	CcSEcCtD
Levetiracetam—Anorexia—Epirubicin—sarcoma	0.00021	0.000873	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—sarcoma	0.000206	0.000854	CcSEcCtD
Levetiracetam—Infection—Doxorubicin—sarcoma	0.000203	0.000842	CcSEcCtD
Levetiracetam—ABCB1—liver—sarcoma	0.000202	0.00746	CbGeAlD
Levetiracetam—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000201	0.000834	CcSEcCtD
Levetiracetam—Nervous system disorder—Doxorubicin—sarcoma	0.0002	0.000831	CcSEcCtD
Levetiracetam—Thrombocytopenia—Doxorubicin—sarcoma	0.0002	0.00083	CcSEcCtD
Levetiracetam—Insomnia—Epirubicin—sarcoma	0.000199	0.000828	CcSEcCtD
Levetiracetam—Skin disorder—Doxorubicin—sarcoma	0.000198	0.000823	CcSEcCtD
Levetiracetam—Paraesthesia—Epirubicin—sarcoma	0.000198	0.000822	CcSEcCtD
Levetiracetam—Somnolence—Epirubicin—sarcoma	0.000196	0.000814	CcSEcCtD
Levetiracetam—Anorexia—Doxorubicin—sarcoma	0.000194	0.000808	CcSEcCtD
Levetiracetam—Dyspepsia—Epirubicin—sarcoma	0.000194	0.000806	CcSEcCtD
Levetiracetam—Decreased appetite—Epirubicin—sarcoma	0.000192	0.000796	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Epirubicin—sarcoma	0.00019	0.000791	CcSEcCtD
Levetiracetam—Fatigue—Epirubicin—sarcoma	0.00019	0.000789	CcSEcCtD
Levetiracetam—Pain—Epirubicin—sarcoma	0.000189	0.000783	CcSEcCtD
Levetiracetam—Constipation—Epirubicin—sarcoma	0.000189	0.000783	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000186	0.000772	CcSEcCtD
Levetiracetam—Insomnia—Doxorubicin—sarcoma	0.000185	0.000766	CcSEcCtD
Levetiracetam—Paraesthesia—Doxorubicin—sarcoma	0.000183	0.000761	CcSEcCtD
Levetiracetam—Feeling abnormal—Epirubicin—sarcoma	0.000182	0.000755	CcSEcCtD
Levetiracetam—Somnolence—Doxorubicin—sarcoma	0.000181	0.000753	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Epirubicin—sarcoma	0.00018	0.000749	CcSEcCtD
Levetiracetam—Dyspepsia—Doxorubicin—sarcoma	0.00018	0.000746	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—sarcoma	0.000177	0.000737	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000176	0.000731	CcSEcCtD
Levetiracetam—Fatigue—Doxorubicin—sarcoma	0.000176	0.00073	CcSEcCtD
Levetiracetam—Pain—Doxorubicin—sarcoma	0.000174	0.000725	CcSEcCtD
Levetiracetam—Constipation—Doxorubicin—sarcoma	0.000174	0.000725	CcSEcCtD
Levetiracetam—Body temperature increased—Epirubicin—sarcoma	0.000174	0.000724	CcSEcCtD
Levetiracetam—Abdominal pain—Epirubicin—sarcoma	0.000174	0.000724	CcSEcCtD
Levetiracetam—Feeling abnormal—Doxorubicin—sarcoma	0.000168	0.000698	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Doxorubicin—sarcoma	0.000167	0.000693	CcSEcCtD
Levetiracetam—Hypersensitivity—Epirubicin—sarcoma	0.000162	0.000675	CcSEcCtD
Levetiracetam—Abdominal pain—Doxorubicin—sarcoma	0.000161	0.00067	CcSEcCtD
Levetiracetam—Body temperature increased—Doxorubicin—sarcoma	0.000161	0.00067	CcSEcCtD
Levetiracetam—Asthenia—Epirubicin—sarcoma	0.000158	0.000657	CcSEcCtD
Levetiracetam—Pruritus—Epirubicin—sarcoma	0.000156	0.000648	CcSEcCtD
Levetiracetam—ABCB1—lymph node—sarcoma	0.000155	0.00572	CbGeAlD
Levetiracetam—Diarrhoea—Epirubicin—sarcoma	0.000151	0.000627	CcSEcCtD
Levetiracetam—Hypersensitivity—Doxorubicin—sarcoma	0.00015	0.000624	CcSEcCtD
Levetiracetam—Asthenia—Doxorubicin—sarcoma	0.000146	0.000608	CcSEcCtD
Levetiracetam—Dizziness—Epirubicin—sarcoma	0.000146	0.000606	CcSEcCtD
Levetiracetam—Pruritus—Doxorubicin—sarcoma	0.000144	0.000599	CcSEcCtD
Levetiracetam—Vomiting—Epirubicin—sarcoma	0.00014	0.000582	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—sarcoma	0.00014	0.00058	CcSEcCtD
Levetiracetam—Rash—Epirubicin—sarcoma	0.000139	0.000577	CcSEcCtD
Levetiracetam—Dermatitis—Epirubicin—sarcoma	0.000139	0.000577	CcSEcCtD
Levetiracetam—Headache—Epirubicin—sarcoma	0.000138	0.000574	CcSEcCtD
Levetiracetam—Dizziness—Doxorubicin—sarcoma	0.000135	0.00056	CcSEcCtD
Levetiracetam—Nausea—Epirubicin—sarcoma	0.000131	0.000544	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—sarcoma	0.00013	0.000539	CcSEcCtD
Levetiracetam—Rash—Doxorubicin—sarcoma	0.000129	0.000534	CcSEcCtD
Levetiracetam—Dermatitis—Doxorubicin—sarcoma	0.000129	0.000534	CcSEcCtD
Levetiracetam—Headache—Doxorubicin—sarcoma	0.000128	0.000531	CcSEcCtD
Levetiracetam—Nausea—Doxorubicin—sarcoma	0.000121	0.000503	CcSEcCtD
